의료 분야 원자간력 현미경 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the atomic force microscopy in healthcare market size is expected to increase from USD 162.70 million in 2025 to USD 174.33 million in 2026 and reach USD 246.22 million by 2031, growing at a CAGR of 7.15% over 2026-2031.

This report is Segmented by Offering (AFM Instruments, and More), by Application (Cellular and Tissue Mechanics, and More), by End User (Academic and Research Institutions, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Atomic Force Microscopy In Healthcare Market Trends and Insights

Biopharma Nanoparticle and Biologics Characterization Demand

The atomic force microscopy market in healthcare is advancing due to the integration of lipid nanoparticle drug delivery and the need for single nanoparticle resolution in development. AFM data provides detailed structural insights, such as mRNA coiling within lipid nanoparticles, surpassing the capabilities of other methods. Bruker's AFM-IR feature on the Dimension platform enhances drug mass fraction quantification, offering a competitive edge over standalone tools. Early adoption of AFM-IR in formulation helps identify batch inconsistencies, reducing late-stage reformulation risks.

Rising Public and Private Nanomedicine R&D Funding

Public and institutional investments are driving growth in the atomic force microscopy market in healthcare. China launched its National Multimode Trans-Scale Biomedical Imaging Center in 2025, focusing on advanced molecular imaging for tumor and brain research. India increased funding for nanomaterials and biotechnology through its Vigyan Dhara scheme and MAHA MedTech Mission, supporting high-precision imaging technologies. These initiatives strengthen procurement cycles at research institutions, fueling demand from academic and contract service providers.

High Capital Cost and Probe Replacement Burden

The high costs of atomic force microscopy (AFM) continue to restrict its adoption in the healthcare market, particularly outside major biopharma sites and research centers. Premium AFM platforms require significant upfront investment, and recurring expenses for specialized probes pose challenges for smaller labs and hospital units. In January 2026, Tanzhen Nano Technology raised over CNY 10 million to scale dry etching-based AFM probe production, aiming to reduce costs by 30-40% while maintaining quality. However, this effort addresses probe costs in China but does not mitigate the broader financial burden of instrument purchases, service contracts, and training. Smaller CROs and labs in emerging markets also face annual service costs of 10-15% of the instrument's value, further hindering adoption.

Other drivers and restraints analyzed in the detailed report include:

1. AI-Enabled Automation and Analysis for Easier AFM Adoption
2. Label-Free Live-Cell and Biomolecular Interaction Imaging Demand
3. Slow Throughput for Scaled Screening Workflows

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, AFM Instruments held a 45.35% share of the atomic force microscopy market in healthcare, highlighting the importance of capital equipment in driving revenue across pharmaceutical, biotech, and academic sectors. The dominance of hardware reflects the complexity of these systems, with each new generation offering advanced imaging modes, reduced noise levels, and enhanced sample compatibility, encouraging lab upgrades. For instance, Oxford Instruments launched the Jupiter Discovery AFM in May 2025, featuring a noise floor under 25 picometers and significantly faster scan rates. Probes and cantilevers remain a reliable revenue stream due to their frequent use in force spectroscopy and nanoindentation workflows.

Software and analytics are projected to grow at an 8.12% CAGR through 2031, making it the fastest-growing segment in the atomic force microscopy market for healthcare. This growth is driven by automated force curve analysis and AI-guided image interpretation, reducing reliance on expert operators. Open frameworks and vendor-specific tools are broadening usability, attracting data scientists and formulation teams. This shift increases switching costs, as customers become reliant on specific software environments for data management and analysis.

Geography Analysis

In 2025, North America accounted for 41.20% of the atomic force microscopy (AFM) market in healthcare, driven by a high concentration of biopharma innovators, a mature research ecosystem, and robust grant funding in mechanobiology and drug delivery. The U.S. leads regional demand as developers integrate AFM-IR into workflows for LNP-based therapeutics, while Canada strengthens academic contributions, and Mexico supports contract research and manufacturing-linked activities. Bruker reported that U.S. revenues represented 26% of its USD 3.44 billion turnover, highlighting North America's purchasing power in scientific instruments.

Europe ranked as the second-largest regional market for atomic force microscopy in healthcare, maintaining leadership in publicly funded correlative AFM research. Germany and the U.K. anchor instrument development, while France, Italy, and Spain expand AFM-IR and multimodal system installations. The University of Bordeaux operates a VibrAFM platform with four coupled AFM systems, including Bruker BioScope instruments, for mechanobiology and cancer research. The University of Miskolc installed an AFM Raman FLIM system in September 2025, one of only three such platforms globally, reflecting Europe's demand for advanced systems.

Asia-Pacific is projected to grow at an 8.55% CAGR through 2031, the fastest among all regions, supported by government-backed infrastructure, expanding nanomedicine research, and large-scale institutional procurements in China, Japan, India, and South Korea. China's National Multimode Trans-Scale Biomedical Imaging Center, with a USD 237 million investment, became a major regional milestone in March 2025. Japan advances high-speed AFM research through Kyoto and Nagoya Universities, while India's MAHA MedTech Mission, valued at USD 90 million, facilitates access to advanced imaging systems. The Middle East, Africa, and South America remain emerging markets, with demand concentrated in GCC countries, South Africa, and Brazil, driven by public institutions and import financing.

1. A.P.E. Research S.r.l.
2. AFMWorkshop, LLC
3. Anton Paar
4. attocube systems AG
5. Bruker
6. CSInstruments
7. DME Scanning Probe Microscopes
8. Hitachi
9. HORIBA Ltd.
10. JEOL Ltd.
11. Molecular Vista, Inc.
12. NanoMagnetics Instruments Ltd.
13. Nanonics Imaging Ltd.
14. Nanoscience Instruments
15. Nanosurf AG
16. NT-MDT Spectrum Instruments
17. Oxford Instruments
18. Park Systems Corporation
19. RHK Technology, Inc.
20. Semilab Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Biopharma Nanoparticle and Biologics Characterization Demand
  • 4.2.2 Rising Public and Private Nanomedicine R&D Funding
  • 4.2.3 AI-Enabled Automation and Analysis for Easier AFM Adoption
  • 4.2.4 Label-Free Live-Cell and Biomolecular Interaction Imaging Demand
  • 4.2.5 Correlative AFM With Raman and Fluorescence Workflows
  • 4.2.6 Biomaterials and Medical-Device Surface Nanomechanics Demand
• 4.3 Market Restraints
  • 4.3.1 High Capital Cost and Probe Replacement Burden
  • 4.3.2 Slow Throughput for Scaled Screening Workflows
  • 4.3.3 Inter-Lab Reproducibility Gaps in Live-Cell Nanomechanics
  • 4.3.4 Limited Clinical Validation of AFM-Derived Biomarkers
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of new entrants
  • 4.7.2 Bargaining power of suppliers
  • 4.7.3 Bargaining power of buyers
  • 4.7.4 Threat of substitutes
  • 4.7.5 Competitive rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Offering
  • 5.1.1 AFM Instruments
  • 5.1.2 Probes and Cantilevers
  • 5.1.3 Software and Analytics
  • 5.1.4 Services
• 5.2 By Application
  • 5.2.1 Cellular and Tissue Mechanics
  • 5.2.2 Biomolecular Imaging and Force Spectroscopy
  • 5.2.3 Drug Discovery and Formulation Characterization
  • 5.2.4 Biomaterials and Medical Device Surface Analysis
  • 5.2.5 Microbiology, Virology, and Biofilms
  • 5.2.6 Clinical Diagnostics and Biosensing Research
• 5.3 By End User
  • 5.3.1 Academic and Research Institutions
  • 5.3.2 Pharmaceutical and Biotechnology Companies
  • 5.3.3 Hospitals and Clinical Research Centers
  • 5.3.4 Contract Research Organizations
  • 5.3.5 Medical Device and Biomaterials Companies
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 A.P.E. Research S.r.l.
  • 6.3.2 AFMWorkshop, LLC
  • 6.3.3 Anton Paar GmbH
  • 6.3.4 attocube systems AG
  • 6.3.5 Bruker Corporation
  • 6.3.6 CSInstruments
  • 6.3.7 DME Scanning Probe Microscopes
  • 6.3.8 Hitachi High-Tech Corporation
  • 6.3.9 HORIBA Ltd.
  • 6.3.10 JEOL Ltd.
  • 6.3.11 Molecular Vista, Inc.
  • 6.3.12 NanoMagnetics Instruments Ltd.
  • 6.3.13 Nanonics Imaging Ltd.
  • 6.3.14 Nanoscience Instruments
  • 6.3.15 Nanosurf AG
  • 6.3.16 NT-MDT Spectrum Instruments
  • 6.3.17 Oxford Instruments plc
  • 6.3.18 Park Systems Corporation
  • 6.3.19 RHK Technology, Inc.
  • 6.3.20 Semilab Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment